SSR4-CDG, an ultra-rare X-linked congenital disorder of glycosylation affecting the TRAP complex: Review of 22 affected individuals including the first adult patient
Open Access
- 18 April 2024
- journal article
- review article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 142 (3) , 108477
Abstract
No abstract availableKeywords
Funding Information
- RDCRN
- NCATS
- NICHD
- NINDS
This publication has 23 references indexed in Scilit:
- Expanding the phenotype of X‐linked SSR4–CDG: Connective tissue implicationsHuman Mutation, 2020
- International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1‐CDG): Diagnosis, follow‐up, and managementJournal of Inherited Metabolic Disease, 2020
- Consensus guideline for the diagnosis and management of mannose phosphate isomerase‐congenital disorder of glycosylationJournal of Inherited Metabolic Disease, 2020
- Mutations in the translocon‐associated protein complex subunit SSR3 cause a novel congenital disorder of glycosylationJournal of Inherited Metabolic Disease, 2019
- Phenotypic variability of patients with protein glycosylation defectsEuropean Journal of Paediatric Neurology, 2017
- Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with AnemiaThe American Journal of Human Genetics, 2016
- Expanding the Molecular and Clinical Phenotype of SSR4-CDGHuman Mutation, 2015
- DDOST Mutations Identified by Whole-Exome Sequencing Are Implicated in Congenital Disorders of GlycosylationThe American Journal of Human Genetics, 2012
- Oligosaccharyltransferase-Subunit Mutations in Nonsyndromic Mental RetardationThe American Journal of Human Genetics, 2008
- A Defect in the TUSC3 Gene Is Associated with Autosomal Recessive Mental RetardationThe American Journal of Human Genetics, 2008